8 Best Middle East and Africa Stocks to Buy According to Hedge Funds
The United States and Israel’s strikes on Iran have roiled global oil prices and reignited volatility across global financial markets.
Posts Tagged ‘NYSE:TEVA’
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2026 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2026 Earnings Call Transcript April 29, 2026Teva Pharmaceutical Industries Limited beats earnings expectations.
Is Teva Pharmaceutical Industries Limited (TEVA) A Good Stock To Buy Now?
Is TEVA a good stock to buy? We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra.
Billionaire Druckenmiller and Jim Cramer Like These Stocks
Stanley Druckenmiller and Jim Cramer are two of the closely followed voices in financial markets.
10 Stocks Notching Impressive Double-Digit Gains
Ten stocks boasted double-digit gains on Wednesday, with six soaring to fresh record highs, as investors took heart from a flurry of strong corporate earnings in the first quarter...
15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026
David Einhorn, the founder and president of Greenlight Capital, is widely regarded as one of the most intellectually rigorous and disciplined value investors of his generation...
David Einhorn Stock Portfolio: Top 10 Stock Picks
David Einhorn of Greenlight Capital manages a 13F portfolio that was worth more than $2.8 billion at the end of the fourth quarter of 2025.
8 Cheap Large Cap Stocks to Buy Now
Cheap large-cap stocks are getting more attention as investors are looking past the market’s most crowded winners and are now putting more weight on the current entry points...
Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential
Stanley Druckenmiller, the founder of New York-based Duquesne Family Office, oversees a 13F portfolio at his hedge fund that was worth close to $4.5 billion at the end of the ...
Factors Supporting Teva Pharmaceutical’s (TEVA) Long-Term Profitability
TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here...
13 Cheapest Strong Buy Stocks to Buy Right Now
Buying stocks with a low forward Price-to-Earnings (P/E) ratio is a classic value-investing approach centered on identifying companies that may be undervalued relative to their...
Is Teva Pharmaceutical Industries (TEVA) A Good Stock To Buy Now?
Is TEVA a good stock to buy? We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra.
Where is Teva Pharmaceutical Industries Limited (TEVA) Headed?
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy healthcare stocks to invest in.
11 Best Strong Buy Healthcare Stocks to Invest In
On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the stock market and the recent price action in stocks...
Truist Boosts Teva (TEVA) Stock Target Amid Pipeline Growth Opportunities
Teva Pharmaceutical Industries Limited (NYSE:TEVA) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks.
Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026
TheFly reported on February 9 that Goldman Sachs raised its price target on TEVA to $45 from $36, and gave it a Buy rating.
Stanley Druckenmiller Stock Portfolio: 10 Best Stock Picks
Stanley Druckenmiller originally rose to prominence by managing George Soros' Quantum Fund, where he oversaw the $10 billion currency bet that "broke the Bank of England" in 1992...
10 Best Performing Foreign Stocks to Buy Now
On January 6, Tim Seymour of Seymour Asset Management appeared on a CNBC Television interview to discuss whether the international markets rally has legs to continue in 2026...
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
According to research, the U.S.
Here’s What Analysts Are Saying About Teva Pharmaceutical (TEVA) Post Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks under $50 to invest in.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage...
Is Teva Pharmaceutical Industries Limited (TEVA) an Undervalued Stock Relative to Its Long-Term Potential?
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here.
Barclays Raises Teva Pharmaceutical (TEVA) PT to $38 Following Strong Q4 Earnings Beat
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the cheap hot stocks to invest in right now.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra.
11 Cheap Hot Stocks to Invest In Right Now
On January 23, Ryan Detrick, Carson Group chief market strategist, appeared on CNBC's 'Squawk Box' to discuss the latest market trends and the outlook for 2026.
Analysts See Pipeline Catalysts Driving Teva Pharmaceutical Industries Limited (TEVA)’s 2026 Growth Despite Revenue Headwinds
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks to buy for 2026.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
Jim Cramer’s Takes on 19 Stocks and Navigating Market Shortages
When in doubt, ask if there's a shortage or a glut of what the company in question sells. If it's the former, then you can buy.
What Makes Teva Pharmaceuticals (TEVA) a Successful Brand?
Greenlight Capital, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript January 28, 2026Teva Pharmaceutical Industries Limited beats earnings expectations.
Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best performing pharma stocks in 2025.
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and...
What Do Analysts Think About Teva Pharmaceutical Industries (TEVA)?
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable healthcare stocks to buy now.
10 Best Affordable Healthcare Stocks to Buy Now
On December 26, Bernstein analyst Lance Wilkes appeared on CNBC to talk about the outlook for the managed care providers in 2026, along with how the rising healthcare costs could...
BofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight
TheFly reported on December 9 that Bank of America Securities analyst Jason Gerberry reaffirmed a Buy rating on TEVA and raised his price target to $32.00, reflecting conviction...
9 Most Undervalued Pharma Stocks to Buy Right Now
The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.
Teva (TEVA) Hits Multi-Year High as Q3 Strengthens FY25 Profitability Expectations
This followed the company’s net income of $460 million in the third quarter of the year, marking a 211 percent improvement from the $390 million net loss in the same period ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2025 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2025 Earnings Call Transcript November 5, 2025Teva Pharmaceutical Industries Limited misses on earnings expectations.
Teva Pharmaceutical (TEVA) Enters Into a License Agreement With Prestige Biopharma for the Commercialization of Tuznue in Europe
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable stocks to buy under $20.
14 Best Affordable Stocks to Buy Under $20
On October 22, Alan Rechtschaffen, UBS Global Wealth senior portfolio manager, appeared on CNBC’s ‘Money Movers’ to talk about the latest trends in the market.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra.
13 Best Growth Stocks Under $25 to Buy Right Now
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
11 Dirt Cheap Stocks to Buy According to Analysts
Stocks gained more in afternoon trading after US Treasury Secretary Scott Bessent announced he would speak with his Chinese trade counterpart.
Teva Pharmaceutical Receives FDA Approval to Expand UZEDY Indication for Maintenance Treatment of Bipolar I Disorder
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street analysts.
14 Best High Volume Stocks to Buy According to Wall Street Analysts
On October 9, Keith Buchanan, Senior Portfolio Manager at GLOBALT Investments, appeared on CNBC and stated that the markets show mixed signals of risk and optimism.
BofA Raises Teva Pharmaceutical (TEVA) PT to $24, Amid “Pivot to Growth” Strategy Execution
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks under $100.
14 Most Promising Stocks Under $100
On October 10, Tom Lee of Fundstrat joined 'Closing Bell' on CNBC to suggest that the S&P can still get to at least 7,000 this year.
UBS Maintains its Buy Rating on Teva Pharmaceutical Industries Limited (TEVA); Raises Its Price Target to $26.00
UBS raised its 2030 sales estimate from $6.3 billion to $6.6 billion, taking into account possible income from Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s new inhaler...
Truist Securities Reaffirms Its Buy Rating for Teva Pharmaceutical Industries Limited (TEVA)
On September 23, 2025, Truist Securities reaffirmed its Buy rating for Teva Pharmaceutical Industries Limited (NYSE:TEVA), maintaining its $25 price target, following a recap ...
12 Best Widow and Orphan Stocks to Buy According to Analysts
According to Reuters, U.S. stock index futures increased on September 29.
Hedge Fund Resource Center
